These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29484995)

  • 21. Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology.
    Andrés-Guerrero V; Zong M; Ramsay E; Rojas B; Sarkhel S; Gallego B; de Hoz R; Ramírez AI; Salazar JJ; Triviño A; Ramírez JM; Del Amo EM; Cameron N; de-Las-Heras B; Urtti A; Mihov G; Dias A; Herrero-Vanrell R
    J Control Release; 2015 Aug; 211():105-17. PubMed ID: 26003040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal therapeutic nanoparticles for age-related macular degeneration: Design principles, progress and opportunities.
    Zhang Y; Watson S; Ramaswamy Y; Singh G
    Adv Colloid Interface Sci; 2024 Jul; 329():103200. PubMed ID: 38788306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release.
    Martínez-Sancho C; Herrero-Vanrell R; Negro S
    Int J Pharm; 2006 Dec; 326(1-2):100-6. PubMed ID: 16945492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotherapy for posterior eye diseases.
    Kaur IP; Kakkar S
    J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Potential of liposomes for the intravitreal injection of therapeutic molecules].
    Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E
    Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug micro-carriers with a hyaluronic acid corona toward a diffusion-limited aggregation within the vitreous body.
    Mayol L; Silvestri T; Fusco S; Borzacchiello A; De Rosa G; Biondi M
    Carbohydr Polym; 2019 Sep; 220():185-190. PubMed ID: 31196539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
    Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L
    J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable microspheres for protein delivery.
    Sinha VR; Trehan A
    J Control Release; 2003 Jul; 90(3):261-80. PubMed ID: 12880694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal nanoparticles for retinal delivery.
    Huang X; Chau Y
    Drug Discov Today; 2019 Aug; 24(8):1510-1523. PubMed ID: 31102730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microparticulate poly(vinyl alcohol) hydrogel formulations for embedding and controlled release of polyethylenimine (PEI)-based nanoparticles.
    Schulze J; Hendrikx S; Schulz-Siegmund M; Aigner A
    Acta Biomater; 2016 Nov; 45():210-222. PubMed ID: 27592816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modern drug delivery systems for targeting the posterior segment of the eye.
    Peptu CA; Popa M; Savin C; Popa RF; Ochiuz L
    Curr Pharm Des; 2015; 21(42):6055-69. PubMed ID: 26503152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
    Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles for the treatment of ocular neovascularizations.
    Hennig R; Goepferich A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):294-306. PubMed ID: 25758124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization, and in vivo evaluation of triamcinolone acetonide microspheres after intravitreal administration.
    Zarei-Ghanavati S; Malaekeh-Nikouei B; Pourmazar R; Seyedi S
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):502-6. PubMed ID: 22537291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball.
    Xue R; Wu H; Li S; Pu N; Wei D; Zhao N; Cui Y; Li H; Song Z; Tao Y
    Mater Today Bio; 2024 Aug; 27():101126. PubMed ID: 38994470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats.
    Fernández-Sánchez L; Bravo-Osuna I; Lax P; Arranz-Romera A; Maneu V; Esteban-Pérez S; Pinilla I; Puebla-González MDM; Herrero-Vanrell R; Cuenca N
    PLoS One; 2017; 12(5):e0177998. PubMed ID: 28542454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable implants for sustained drug release in the eye.
    Lee SS; Hughes P; Ross AD; Robinson MR
    Pharm Res; 2010 Oct; 27(10):2043-53. PubMed ID: 20535532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug delivery to the posterior segment of the eye.
    Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
    Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in ocular drug delivery.
    Chen H
    J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.